Thermo Fisher Scientific cut the ribbon to open a highly automated manufacturing plant in North Carolina—featuring a 375,000-square-foot facility capable…

Masimo is taking the U.S. government to court over its decision to allow blood oxygen tracking to return to the…

The developer of an alternative surgical approach to glaucoma has raised $42 million to bolster the commercial launch of its…

A new continuous glucose monitoring approach is making its debut over-the-counter—one that’s aimed not specifically at people with diabetes, but…

The maker of a new category of small, wearable insulin patch pumps—designed to comfortably provide therapy to people with diabetes…

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with…

In an update to their guidelines for treating high blood pressure, a group of cardiovascular medical societies has included a…

Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated.  Last month, the company…

Philips is planning to invest at least $150 million in new funding for its U.S. production base, including through the…

Shortly after welcoming a new CEO, robot developer Vicarious Surgical reported that it will be delaying the clinical trials planned…